Funded by Movember a UniSA study has tracked the scale and timing of mental health issues among 13,693 South Australian men with prostate cancer.
The study found that 15 per cent of prostate cancer patients began mental health medications directly after a prostate cancer diagnosis, with 6 per cent seeking help from mental health services.
Lead researcher UniSA’s Dr Tenaw Tiruye says the study highlights an acute need to offer mental health services and support for all men diagnosed with prostate cancer.
“Prostate cancer is the most common cancer affecting Australian men. But despite high survival rates, psychological issues are one of the most frequently reported unmet needs among prostate cancer survivors,” Dr Tiruye says.
“Prostate cancer can take a serious toll on the mental health of men throughout all stages of the illness – including diagnosis, surveillance, treatment, and follow‐up – with an estimated one in six people experiencing clinical depression.
“In fact, the rates of depression and anxiety among prostate cancer patients are significantly higher than those in the general population, as is the risk of suicide.
“In our study we found that 15 per cent of patients started anti-anxiety and antidepression medications at the time of their diagnosis, and that 6 per cent looked for mental health support. This shows that men are more likely to commence psychotropic medications than seek out mental health services.
“But it also shows a significant gap, which is those men who have not sought help.”
Senior researcher, UniSA’s Dr Kerri Beckmann says fewer than a quarter of men ask for help when it comes to their mental health.
“Whether it’s the stigma surrounding mental health, or a fear about being seen as weak, statistics shows that many men struggle to seek help for mental health concerns,” Dr Beckmann says.
“So, rather than waiting for men to proactively seek out mental health supports once they’ve been diagnosed with prostate cancer, we should be offering supports at the time of diagnosis and throughout treatment. That way it can be seen as a normal and required part of treatment.
“Only by normalising mental health discussions, can we improve access to wellbeing tools and services, to ensure that men with prostate cancer have every opportunity to voice their struggles and receive the support they need.”
